Vesocclude Medical LLC is categorized under Health Services in Raleigh, NC and active since 2013.
Vesocclude Medical LLC was established in 2013, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Health Services business, which does work in the B2C market, and is classified as a Health Services, under code number 621999 by the NAICS.
If you are seeking more information, feel free to contact Lynch J Christopher at the company’s single location by writing to 7429 Acc Boulevard # 101, Raleigh, North Carolina NC 27617 or by phoning (919) 596-7711. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Vesocclude Medical LLC |
| Contact Person: | Lynch J Christopher |
| Address: | 7429 Acc Boulevard # 101, Raleigh, North Carolina 27617 |
| Phone Number: | (919) 596-7711 |
| Website Address: | vesoccludemedical.com |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2013 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Health Services |
| SIC Code: | 8099 |
| NAICS Code: | 621999 |
| Share This Business: |
Vesocclude Medical LLC was started in 2013 to provide professional Health Services under the SIC code 8099 and NAICS code 621999. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Lynch J Christopher for inquiries that concern Vesocclude Medical LLC by calling the company number (919) 596-7711, as your correspondence is most welcome. Additionally, the physical location of the single location of Vesocclude Medical LLC can be found at the coordinates 35.910791,-78.767678 as well as the street address 7429 Acc Boulevard # 101 in Raleigh, North Carolina 27617.
For its online presence, you may visit Vesocclude Medical LLC’s website at vesoccludemedical.com and engage with its social media outlets through on Twitter and on Facebook.